Infectious complications as the leading cause of death after kidney transplantation: analysis of more than 10,000 transplants from a single center
Abstract
Aim
To identify specific causes of graft failure in a large sample of kidney transplant patients from a middle-income, developing country.
Methods
Retrospective cohort study analyzing all consecutive single kidney transplants (KTs) performed at a single center in Brazil between January 1st 1998 and December 31st 2013. The database closing date was December 31st 2014.
Results
Out of 10,400 KTs, there were 1191 (11.45%) deaths with a functioning graft, 40 cases (0.38%) of primary non-function (PNF) and 1417 cases (13.62%) of graft loss excluding death and PNF as the cause. Infectious complications (404 cases, 34% of all deaths) were the major cause of death. Most deaths due to infection occurred within the first year after transplantation (157 deaths, 38.86%). Immunologic mechanisms, comprising acute rejection and immune-mediated interstitial fibrosis/tubular atrophy (IF/TA), were responsible for 52% of all cases of graft failure not involving recipient death. Half of the losses by acute rejection occurred late after transplantation.
Conclusion
Contrary to what is observed in developed countries, infectious complications are the main challenge with kidney transplantation in Brazil. Non-adherence to treatment also appears to contribute significantly to long-term kidney graft loss. Strategies for improvement should focus on better compliance and a greater safety profile of immunosuppressive treatment.
Keywords
Kidney transplantation Patient survival Graft loss Infectious diseases Acute rejectionNotes
Compliance with ethical standards
Conflict of interest
FCRF: no conflict of interests to declare. MPC: travel grants for Novartis, Alexion, Pfizer, Libbs. Eventual speaker for: Novartis, Alexion, Pfizer, Libbs, Sanofi. MIP: travel grants from Libbs. HP: travel grants from Novartis. CRF: no conflict of interests to declare. HTS: clinical investigation fundings from Novartis, Pfizer, Sanofi, Roche. JOMP: travel grants for Novartis.
Ethical standards and informed consent statements
All procedures performed in the present study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Due to the retrospective nature of this study, formal consent was not required.
References
- 1.O’Regan JA, Canney M, Connaughton DM, O’Kelly P, Williams Y, Collier G, deFreitas DG, O’Seaghdha CM, Conlon PJ (2016) Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. J Nephrol 29(2):269–276CrossRefPubMedGoogle Scholar
- 2.Karim A, Farrugia D, Cheshire J, Mahboob S, Begaj I, Ray D, Sharif A (2014) Recipient age and risk for mortality after kidney transplantation in England. Transplantation 97(8):832–838CrossRefPubMedGoogle Scholar
- 3.Ma MK, Lim WH, Craig JC, Russ GR, Chapman JR, Wong G (2016) Mortality among younger and older recipients of kidney transplants from expanded criteria donors compared with standard criteria donors. Clin J Am Soc Nephrol 11(1):128–136CrossRefPubMedGoogle Scholar
- 4.Gondos A, Döhler B, Brenner H, Opelz G (2013) Kidney graft survival in Europe and the United states: strikingly different long-term outcomes. Transplantation 95(2):267–274CrossRefPubMedGoogle Scholar
- 5.Wang JH, Skeans MA, Israni AK (2016) Current status of kidney transplant outcomes: dying to survive. Adv Chronic Kidney Dis 23(5):281–286CrossRefPubMedGoogle Scholar
- 6.Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4(3):378–383CrossRefPubMedGoogle Scholar
- 7.El-Zoghby ZM, Stegall MD, Lager DJ, Kremers WK, Amer H, Gloor JM, Cosio FG (2009) Identifying specific causes of kidney allograft loss. Am J Transplant 9(3):527–535CrossRefPubMedGoogle Scholar
- 8.Naesens M, Kuypers DR, De Vusser K, Evenepoel P, Claes K, Bammens B, Meijers B, Sprangers B, Pirenne J, Monbaliu D, Jochmans I, Lerut E (2014) The histology of kidney transplant failure: a long-term follow-up study. Transplantation 98(4):427–435CrossRefPubMedGoogle Scholar
- 9.United States Renal Data System (2015) http://www.usrds.org. 2015 Annual Data Report. [Online] 2015. [Cited: https://www.usrds.org/adr.aspx]
- 10.Australia and New Zealand Dialysis and Transplant Registry (2016) ANZDATA Registry. 38th Report, Chap. 8: Transplantation. [Online] 2016. [Cited: http://www.anzdata.org.au/anzdata/AnzdataReport/38thReport/c08_anzdata_transplantation_v2.0_20160128_web.pdf]
- 11.Gill JS, Tonelli M (2012) Penny wise, pound foolish? Coverage limits on immunosuppression after kidney transplantation. N Engl J Med 366(7):586–589CrossRefPubMedGoogle Scholar
- 12.Garcia-Garcia G, Jha V (2015) CKD in disadvantaged populations. J Nephrol 28(1):1–5CrossRefPubMedGoogle Scholar
- 13.Woodward RS, Page TF, Soares R, Schnitzler MA, Lentine KL, Brennan DC (2008) Income-related disparities in kidney transplant graft failures are eliminated by Medicare’s immunosuppression coverage. Am J Transplant 8(12):2636–2646CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ (2010) Reduction in cardiovascular death after kidney transplantation. Transplantation 89(7):851–857CrossRefPubMedGoogle Scholar
- 15.Marcos LA, Machicado JD (2014) Soil-transmitted helminth infections in South America. Lancet Infect Dis 14(3):183CrossRefPubMedGoogle Scholar
- 16.Meinerz G, da Silva CK, Goldani JC, Garcia VD, Keitel E (2016) Epidemiology of tuberculosis after kidney transplantation in a developing country. Transpl Infect Dis 18(2):176–182CrossRefPubMedGoogle Scholar
- 17.Batista MV, Pierrotti LC, Abdala E, Clemente WT, Girão ES, Rosa DR, Ianhez LE, Bonazzi PR, Lima AS, Fernandes PF, Pádua-Neto MV, Bacchella T, Oliveira AP, Viana CF, Ferreira MS, Shikanai-Yasuda MA (2011) Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 16(9):1134–1142CrossRefPubMedGoogle Scholar
- 18.World Health Organization (2015) Global Health Observatory data repository, MDG Developed region, Latin America and the Caribbean. [Online] 2015. [Cited: http://apps.who.int/gho/data/view.main.RCODMDGLACV?lang=en]
- 19.Rodrigues CA, Franco MF, Cristelli MP, Pestana JO, Tedesco-Silva H Jr (2014) Clinicopathological characteristics and effect of late acute rejection on renal transplant outcomes. Transplantation 98(8):885–892CrossRefPubMedGoogle Scholar
- 20.Krisl JC, Alloway RR, Shield AR, Govil A, Mogilishetty G, Cardi M, Diwan T, Abu Jawdeh BG, Girnita A, Witte D, Woodle ES (2015) Acute rejection clinically defined phenotypes correlate with long-term renal allograft survival. Transplantation 99(10):2167–2173CrossRefPubMedGoogle Scholar
- 21.Evans RW, Applegate WH, Briscoe DM, Cohen DJ, Rorick CC, Murphy BT, Madsen JC (2010) Cost-related immunosuppressive medication nonadherence among kidney transplant recipients. Clin J Am Soc Nephrol 5(12):2323–2328CrossRefPubMedPubMedCentralGoogle Scholar